172 related articles for article (PubMed ID: 30776883)
21. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
[TBL] [Abstract][Full Text] [Related]
22. Soft-tissue sarcoma in adolescents and young adults compared with older adults: A report among 5000 patients from the Scandinavian Sarcoma Group Central Register.
Papworth KE; Arroyo VM; Styring E; Zaikova O; Melin BS; Lupo PJ
Cancer; 2019 Oct; 125(20):3595-3602. PubMed ID: 31287163
[TBL] [Abstract][Full Text] [Related]
23. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).
Sleijfer S; Ray-Coquard I; Papai Z; Le Cesne A; Scurr M; Schöffski P; Collin F; Pandite L; Marreaud S; De Brauwer A; van Glabbeke M; Verweij J; Blay JY
J Clin Oncol; 2009 Jul; 27(19):3126-32. PubMed ID: 19451427
[TBL] [Abstract][Full Text] [Related]
24. Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspective.
Bae S; Brnabic A; Crowe P; Carey-Smith R; Andelkovic V; Singhal N; Stalley P; Yip D; Desai J
Asia Pac J Clin Oncol; 2022 Dec; 18(6):605-613. PubMed ID: 35098667
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation.
Gupta S; Gouw L; Wright J; Chawla S; Pitt D; Wade M; Boucher K; Sharma S
Invest New Drugs; 2016 Apr; 34(2):243-52. PubMed ID: 26897615
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.
Brunello A; Rizzato MD; Rastrelli M; Roma A; Maruzzo M; Basso U; Fiduccia P; Buzzaccarini MS; Scarzello G; Rossi CR; Zagonel V
J Cancer Res Clin Oncol; 2016 Mar; 142(3):679-85. PubMed ID: 26547435
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological study of soft-tissue sarcomas in Ireland.
Bhatt N; Deady S; Gillis A; Bertuzzi A; Fabre A; Heffernan E; Gillham C; O'Toole G; Ridgway PF
Cancer Med; 2016 Jan; 5(1):129-35. PubMed ID: 26589778
[TBL] [Abstract][Full Text] [Related]
28. Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
Tap WD; Wagner AJ; Schöffski P; Martin-Broto J; Krarup-Hansen A; Ganjoo KN; Yen CC; Abdul Razak AR; Spira A; Kawai A; Le Cesne A; Van Tine BA; Naito Y; Park SH; Fedenko A; Pápai Z; Soldatenkova V; Shahir A; Mo G; Wright J; Jones RL;
JAMA; 2020 Apr; 323(13):1266-1276. PubMed ID: 32259228
[TBL] [Abstract][Full Text] [Related]
29. Unplanned Excision of Extremity Soft Tissue Sarcoma in Korea: A Nationwide Study Based on a Claims Registry.
Kang S; Kim HS; Han I
PLoS One; 2015; 10(8):e0134354. PubMed ID: 26237049
[TBL] [Abstract][Full Text] [Related]
30. Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients.
Spalato Ceruso M; Napolitano A; Silletta M; Mazzocca A; Valeri S; Improta L; Santini D; Tonini G; Badalamenti G; Vincenzi B
Chemotherapy; 2019; 64(2):105-109. PubMed ID: 31390619
[TBL] [Abstract][Full Text] [Related]
31. Soft tissue sarcoma diagnosed subsequent to lymphoma is associated with prior radiotherapy and decreased survival.
Katz SC; Baldwin K; Karakousis G; Moraco N; Buglino A; Singer S; Brennan MF
Cancer; 2011 Oct; 117(20):4756-63. PubMed ID: 21465463
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
[TBL] [Abstract][Full Text] [Related]
33. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.
Mastrangelo G; Coindre JM; Ducimetière F; Dei Tos AP; Fadda E; Blay JY; Buja A; Fedeli U; Cegolon L; Frasson A; Ranchère-Vince D; Montesco C; Ray-Coquard I; Rossi CR
Cancer; 2012 Nov; 118(21):5339-48. PubMed ID: 22517534
[TBL] [Abstract][Full Text] [Related]
34. Soft Tissue Sarcomas: A 16-Year Experience of a Tertiary Referral Hospital in North Jordan.
Alorjani MS; Matalka II; Alfaqih MA; Jahmani RA; Alsinglawi BS; Nimri FM; Matalka MI; Amr SS
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208522
[No Abstract] [Full Text] [Related]
35. Minimal Increase in Survival Throughout the Years in Patients with Soft Tissue Sarcoma with Synchronous Metastases: Results of a Population-Based Study.
Vos M; Ho VKY; Oosten AW; Verhoef C; Sleijfer S
Oncologist; 2019 Jul; 24(7):e526-e535. PubMed ID: 30190301
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
37. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.
Movva S; von Mehren M; Ross EA; Handorf E
J Natl Compr Canc Netw; 2015 Nov; 13(11):1366-74. PubMed ID: 26553766
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.
Schuler MK; Gerdes S; West A; Richter S; Busemann C; Hentschel L; Lenz F; Kopp HG; Ehninger G; Reichardt P; Pink D
BMC Cancer; 2016 Aug; 16():619. PubMed ID: 27507014
[TBL] [Abstract][Full Text] [Related]
39. High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor response.
Crombé A; Le Loarer F; Cornelis F; Stoeckle E; Buy X; Cousin S; Italiano A; Kind M
Eur Radiol; 2019 Feb; 29(2):545-555. PubMed ID: 30039222
[TBL] [Abstract][Full Text] [Related]
40. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
Kopp HG; Patel S; Brücher B; Hartmann JT
Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
